{"id":8176,"date":"2017-01-05T10:04:44","date_gmt":"2017-01-05T09:04:44","guid":{"rendered":"http:\/\/igcz.poznan.pl\/en\/?p=8176"},"modified":"2017-06-20T10:50:42","modified_gmt":"2017-06-20T08:50:42","slug":"new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart","status":"publish","type":"post","link":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/","title":{"rendered":"<strong>New publication <\/strong> Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure."},"content":{"rendered":"<p>Gwizdala A,<strong> Rozwadowska N, Kolanowski TJ, Malcher A, <\/strong>Cieplucha A, Perek B, Seniuk W, Straburzynska-Migaj E, Oko-Sarnowska Z, Cholewinski W, Michalak M, Grajek S, <strong><b>Kurpisz M<\/b><\/strong><br \/>\n<span style=\"font-size: 10pt; color: #999999;\"><span class=\"jrnl\" title=\"European journal of heart failure\">Eur J Heart Fail,<\/span> 2017 Jan;19 (1):148-157, IF-<strong>6,986<\/strong>, MNiSW<strong>-40<\/strong><strong>.<\/strong><\/span><strong><br \/>\n<\/strong><\/p>\n<p><!--more--><\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28052545\">Link to publication<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gwizdala A, Rozwadowska N, Kolanowski TJ, Malcher A, Cieplucha A, Perek B, Seniuk W, Straburzynska-Migaj E, Oko-Sarnowska Z, Cholewinski W, Michalak M, Grajek S, Kurpisz M Eur J Heart Fail, 2017 Jan;19 (1):148-157, IF-6,986, MNiSW-40.<\/p>\n","protected":false},"author":69,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[135],"tags":[],"class_list":["post-8176","post","type-post","status-publish","format-standard","hentry","category-new-publication"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New publication  Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. - Institute of Human Genetics Polish Academy of Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New publication  Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. - Institute of Human Genetics Polish Academy of Sciences\" \/>\n<meta property=\"og:description\" content=\"Gwizdala A, Rozwadowska N, Kolanowski TJ, Malcher A, Cieplucha A, Perek B, Seniuk W, Straburzynska-Migaj E, Oko-Sarnowska Z, Cholewinski W, Michalak M, Grajek S, Kurpisz M Eur J Heart Fail, 2017 Jan;19 (1):148-157, IF-6,986, MNiSW-40.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/\" \/>\n<meta property=\"og:site_name\" content=\"Institute of Human Genetics Polish Academy of Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-05T09:04:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-06-20T08:50:42+00:00\" \/>\n<meta name=\"author\" content=\"Aleksandra Jakubowska-Paw\u0142owska\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Aleksandra Jakubowska-Paw\u0142owska\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/\"},\"author\":{\"name\":\"Aleksandra Jakubowska-Paw\u0142owska\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#\\\/schema\\\/person\\\/f2d8e587749273aae3563980b3a98893\"},\"headline\":\"New publication Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\\\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.\",\"datePublished\":\"2017-01-05T09:04:44+00:00\",\"dateModified\":\"2017-06-20T08:50:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/\"},\"wordCount\":63,\"articleSection\":[\"New publication\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/\",\"url\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/\",\"name\":\"New publication Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\\\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. - Institute of Human Genetics Polish Academy of Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#website\"},\"datePublished\":\"2017-01-05T09:04:44+00:00\",\"dateModified\":\"2017-06-20T08:50:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#\\\/schema\\\/person\\\/f2d8e587749273aae3563980b3a98893\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/new-publication\\\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New publication\",\"item\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/kategoria\\\/new-publication\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"New publication Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\\\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#website\",\"url\":\"https:\\\/\\\/igcz.poznan.pl\\\/\",\"name\":\"Institute of Human Genetics Polish Academy of Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/igcz.poznan.pl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/igcz.poznan.pl\\\/#\\\/schema\\\/person\\\/f2d8e587749273aae3563980b3a98893\",\"name\":\"Aleksandra Jakubowska-Paw\u0142owska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4ea1001a58458f49385830c673cc4fd66ac2ba960ab1ce7f308d651fc660c7a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4ea1001a58458f49385830c673cc4fd66ac2ba960ab1ce7f308d651fc660c7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4ea1001a58458f49385830c673cc4fd66ac2ba960ab1ce7f308d651fc660c7a5?s=96&d=mm&r=g\",\"caption\":\"Aleksandra Jakubowska-Paw\u0142owska\"},\"url\":\"https:\\\/\\\/igcz.poznan.pl\\\/en\\\/pracownik\\\/aleksandra-jakubowska-pawlowska\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New publication  Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. - Institute of Human Genetics Polish Academy of Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/","og_locale":"en_US","og_type":"article","og_title":"New publication  Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. - Institute of Human Genetics Polish Academy of Sciences","og_description":"Gwizdala A, Rozwadowska N, Kolanowski TJ, Malcher A, Cieplucha A, Perek B, Seniuk W, Straburzynska-Migaj E, Oko-Sarnowska Z, Cholewinski W, Michalak M, Grajek S, Kurpisz M Eur J Heart Fail, 2017 Jan;19 (1):148-157, IF-6,986, MNiSW-40.","og_url":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/","og_site_name":"Institute of Human Genetics Polish Academy of Sciences","article_published_time":"2017-01-05T09:04:44+00:00","article_modified_time":"2017-06-20T08:50:42+00:00","author":"Aleksandra Jakubowska-Paw\u0142owska","twitter_misc":{"Written by":"Aleksandra Jakubowska-Paw\u0142owska"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/#article","isPartOf":{"@id":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/"},"author":{"name":"Aleksandra Jakubowska-Paw\u0142owska","@id":"https:\/\/igcz.poznan.pl\/#\/schema\/person\/f2d8e587749273aae3563980b3a98893"},"headline":"New publication Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.","datePublished":"2017-01-05T09:04:44+00:00","dateModified":"2017-06-20T08:50:42+00:00","mainEntityOfPage":{"@id":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/"},"wordCount":63,"articleSection":["New publication"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/","url":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/","name":"New publication Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. - Institute of Human Genetics Polish Academy of Sciences","isPartOf":{"@id":"https:\/\/igcz.poznan.pl\/#website"},"datePublished":"2017-01-05T09:04:44+00:00","dateModified":"2017-06-20T08:50:42+00:00","author":{"@id":"https:\/\/igcz.poznan.pl\/#\/schema\/person\/f2d8e587749273aae3563980b3a98893"},"breadcrumb":{"@id":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/igcz.poznan.pl\/en\/new-publication\/new-publication-safety-feasibility-and-effectiveness-of-first-in-human-administration-of-muscle-derived-stemprogenitor-cells-modified-with-connexin-43-gene-for-treatment-of-advanced-chronic-heart\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/igcz.poznan.pl\/en\/"},{"@type":"ListItem","position":2,"name":"New publication","item":"https:\/\/igcz.poznan.pl\/en\/kategoria\/new-publication\/"},{"@type":"ListItem","position":3,"name":"New publication Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem\/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure."}]},{"@type":"WebSite","@id":"https:\/\/igcz.poznan.pl\/#website","url":"https:\/\/igcz.poznan.pl\/","name":"Institute of Human Genetics Polish Academy of Sciences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/igcz.poznan.pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/igcz.poznan.pl\/#\/schema\/person\/f2d8e587749273aae3563980b3a98893","name":"Aleksandra Jakubowska-Paw\u0142owska","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4ea1001a58458f49385830c673cc4fd66ac2ba960ab1ce7f308d651fc660c7a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4ea1001a58458f49385830c673cc4fd66ac2ba960ab1ce7f308d651fc660c7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4ea1001a58458f49385830c673cc4fd66ac2ba960ab1ce7f308d651fc660c7a5?s=96&d=mm&r=g","caption":"Aleksandra Jakubowska-Paw\u0142owska"},"url":"https:\/\/igcz.poznan.pl\/en\/pracownik\/aleksandra-jakubowska-pawlowska\/"}]}},"_links":{"self":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/posts\/8176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/users\/69"}],"replies":[{"embeddable":true,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/comments?post=8176"}],"version-history":[{"count":8,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/posts\/8176\/revisions"}],"predecessor-version":[{"id":9184,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/posts\/8176\/revisions\/9184"}],"wp:attachment":[{"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/media?parent=8176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/categories?post=8176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/igcz.poznan.pl\/en\/wp-json\/wp\/v2\/tags?post=8176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}